Top Performing Drug – Enbrel (June Edition)
PharmaShots
JUNE 28, 2023
In July 2002, Amgen acquired the rights to Enbrel as part of its acquisition of Immunex. Amgen and Pfizer collaboration Enbrel was launched in November 1998 by Immunex. Before this, Immunex entered an agreement with Wyeth to promote Enbrel in the U.S. and Canada.
40 
Let's personalize your content